{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:18:03Z","timestamp":1761513483617},"reference-count":139,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["bprclinrheum.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.berh.2014.05.002","type":"journal-article","created":{"date-parts":[[2014,6,26]],"date-time":"2014-06-26T05:47:31Z","timestamp":1403761651000},"page":"229-246","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Update on research and clinical translation on specific clinical areas: From bench to bedside: How insight in immune pathogenesis can lead to precision medicine of severe juvenile idiopathic arthritis"],"prefix":"10.1016","volume":"28","author":[{"given":"Sebastiaan","family":"Vastert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berent","family":"Prakken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.berh.2014.05.002_bib1","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","article-title":"Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.\u2013U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and the Cooperative Children's Study Group","volume":"326","author":"Giannini","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.berh.2014.05.002_bib2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/art.1780230403","article-title":"Gold therapy in the management of juvenile rheumatoid arthritis","volume":"23","author":"Brewer","year":"1980","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2014.05.002_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0031-3955(16)33968-2","article-title":"Pharmacotherapy of juvenile rheumatoid arthritis","volume":"28","author":"Lindsley","year":"1981","journal-title":"Pediatr Clin North Am"},{"issue":"20","key":"10.1016\/j.berh.2014.05.002_bib4","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1056\/NEJM198605153142001","article-title":"Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.\u2013U.S.S.R. double-blind placebo-controlled trial","volume":"314","author":"Brewer","year":"1986","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.berh.2014.05.002_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrrheum.2010.5","article-title":"Methotrexate\u2013how does it really work?","volume":"6","author":"Chan","year":"2010","journal-title":"Nat Rev Rheumatol"},{"issue":"14","key":"10.1016\/j.berh.2014.05.002_bib6","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.1993.03500140081040","article-title":"Anticytokine strategies in the treatment of the systemic inflammatory response syndrome","volume":"269","author":"Dinarello","year":"1993","journal-title":"J\u00a0Am Med Assoc"},{"issue":"7","key":"10.1016\/j.berh.2014.05.002_bib7","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/bjo.87.7.879","article-title":"Visual loss in uveitis of childhood","volume":"87","author":"de Boer","year":"2003","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.berh.2014.05.002_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.autrev.2012.07.022","article-title":"Systemic juvenile idiopathic arthritis","volume":"12","author":"Martini","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.berh.2014.05.002_bib9","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nrrheum.2011.68","article-title":"Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions","volume":"7","author":"Mellins","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"10.1016\/j.berh.2014.05.002_bib10","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/1529-0131(199912)42:12<2577::AID-ANR10>3.0.CO;2-O","article-title":"Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5'-flanking region of the TNF alpha gene and HLA genes","volume":"42","author":"Date","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.berh.2014.05.002_bib11","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/art.10882","article-title":"Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis","volume":"48","author":"De Benedetti","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.berh.2014.05.002_bib12","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/1529-0131(200108)44:8<1782::AID-ART314>3.0.CO;2-#","article-title":"A\u00a0novel 5'-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis","volume":"44","author":"Donn","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.berh.2014.05.002_bib13","doi-asserted-by":"crossref","first-page":"R148","DOI":"10.1186\/ar2041","article-title":"Novel IL10 gene family associations with systemic juvenile idiopathic arthritis","volume":"8","author":"Fife","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.berh.2014.05.002_bib14","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI2629","article-title":"The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis","volume":"102","author":"Fishman","year":"1998","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.berh.2014.05.002_bib15","first-page":"912","article-title":"IL10 promoter polymorphisms are associated with systemic onset juvenile idiopathic arthritis (SoJIA)","volume":"28","author":"Moller","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"10.1016\/j.berh.2014.05.002_bib16","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1002\/art.11300","article-title":"The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families","volume":"48","author":"Ogilvie","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.berh.2014.05.002_bib17","doi-asserted-by":"crossref","first-page":"e47673","DOI":"10.1371\/journal.pone.0047673","article-title":"Association of the IL-10 gene family locus on chromosome 1 with juvenile idiopathic arthritis (JIA)","volume":"7","author":"Omoyinmi","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.berh.2014.05.002_bib18","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1002\/art.24601","article-title":"Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis","volume":"60","author":"Barnes","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.berh.2014.05.002_bib19","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1002\/art.22981","article-title":"Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome","volume":"56","author":"Fall","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2014.05.002_bib20","doi-asserted-by":"crossref","first-page":"R123","DOI":"10.1186\/ar3061","article-title":"Immature cell populations and an erythropoiesis gene-expression signature in systemic juvenile idiopathic arthritis: implications for pathogenesis","volume":"12","author":"Hinze","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.berh.2014.05.002_bib21","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/art.22644","article-title":"Specific gene expression profiles in systemic juvenile idiopathic arthritis","volume":"56","author":"Ogilvie","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.berh.2014.05.002_bib22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.it.2004.07.007","article-title":"A\u00a0common pathway in periodic fever syndromes","volume":"25","author":"McDermott","year":"2004","journal-title":"Trends Immunol"},{"issue":"3","key":"10.1016\/j.berh.2014.05.002_bib23","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/art.24349","article-title":"The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis","volume":"60","author":"Frosch","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.berh.2014.05.002_bib24","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/art.23437","article-title":"The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis","volume":"58","author":"Gattorno","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.berh.2014.05.002_bib25","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade","volume":"201","author":"Pascual","year":"2005","journal-title":"J\u00a0Exp Med"},{"issue":"9","key":"10.1016\/j.berh.2014.05.002_bib26","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1084\/jem.20070070","article-title":"Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade","volume":"204","author":"Allantaz","year":"2007","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.berh.2014.05.002_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-065X.2008.00643.x","article-title":"How the study of children with rheumatic diseases identified interferon-alpha and interleukin-1 as novel therapeutic targets","volume":"223","author":"Pascual","year":"2008","journal-title":"Immunol Rev"},{"issue":"2","key":"10.1016\/j.berh.2014.05.002_bib28","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.clim.2009.09.010","article-title":"Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states","volume":"134","author":"Macaubas","year":"2010","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.berh.2014.05.002_bib29","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/art.20198","article-title":"Natural killer cell dysfunction: a common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis?","volume":"50","author":"Grom","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2014.05.002_bib30","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar1453","article-title":"Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome","volume":"7","author":"Villanueva","year":"2005","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.berh.2014.05.002_bib31","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/rheumatology\/keg074","article-title":"Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation","volume":"42","author":"Wulffraat","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2014.05.002_bib32","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","article-title":"Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)","volume":"27","author":"Masters","year":"2009","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"10.1016\/j.berh.2014.05.002_bib33","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1002\/art.24959","article-title":"Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation","volume":"60","author":"Guma","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.berh.2014.05.002_bib34","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1182\/blood.V87.11.4824.bloodjournal87114824","article-title":"Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis","volume":"87","author":"Cazzola","year":"1996","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.berh.2014.05.002_bib35","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/art.1780340912","article-title":"Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis","volume":"34","author":"De Benedetti","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.berh.2014.05.002_bib36","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1172\/JCI117206","article-title":"Serum soluble interleukin 6 (IL-6) receptor and IL-6\/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis","volume":"93","author":"De Benedetti","year":"1994","journal-title":"J\u00a0Clin Invest"},{"issue":"11","key":"10.1016\/j.berh.2014.05.002_bib37","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1210\/endo.142.11.8511","article-title":"Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis","volume":"142","author":"De Benedetti","year":"2001","journal-title":"Endocrinology"},{"issue":"25","key":"10.1016\/j.berh.2014.05.002_bib38","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","article-title":"Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis","volume":"367","author":"De Benedetti","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.berh.2014.05.002_bib39","doi-asserted-by":"crossref","first-page":"R1281","DOI":"10.1186\/ar1826","volume":"7","author":"Woo","year":"2005","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.berh.2014.05.002_bib40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2177\/jsci.27.22","article-title":"Effective application of anti-IL-6-monoclonal antibody for children with systemic-onset juvenile idiopathic arthritis","volume":"27","author":"Yokota","year":"2004","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"issue":"3","key":"10.1016\/j.berh.2014.05.002_bib41","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/art.20944","article-title":"Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis","volume":"52","author":"Yokota","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"9617","key":"10.1016\/j.berh.2014.05.002_bib42","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","article-title":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial","volume":"371","author":"Yokota","year":"2008","journal-title":"Lancet"},{"issue":"1 Pt 1","key":"10.1016\/j.berh.2014.05.002_bib43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0091-6749(99)70518-X","article-title":"IL-18: a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family","volume":"103","author":"Dinarello","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.berh.2014.05.002_bib44","first-page":"483","article-title":"Interleukin-18, a proinflammatory cytokine","volume":"11","author":"Dinarello","year":"2000","journal-title":"Eur Cytokine Netw"},{"issue":"1","key":"10.1016\/j.berh.2014.05.002_bib45","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.semnephrol.2006.09.013","article-title":"Interleukin-18 and the pathogenesis of inflammatory diseases","volume":"27","author":"Dinarello","year":"2007","journal-title":"Semin Nephrol"},{"issue":"6","key":"10.1016\/j.berh.2014.05.002_bib46","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/jlb.63.6.658","article-title":"Overview of interleukin-18: more than an interferon-gamma inducing factor","volume":"63","author":"Dinarello","year":"1998","journal-title":"J\u00a0Leukoc Biol"},{"issue":"5","key":"10.1016\/j.berh.2014.05.002_bib47","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.4049\/jimmunol.167.5.2879","article-title":"A\u00a0role for IL-18 in neutrophil activation","volume":"167","author":"Leung","year":"2001","journal-title":"J\u00a0Immunol"},{"issue":"5","key":"10.1016\/j.berh.2014.05.002_bib48","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/ard.2006.061853","article-title":"Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study","volume":"66","author":"de Jager","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.berh.2014.05.002_bib49","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1007\/s10067-006-0474-0","article-title":"Interleukin-18 as a mediator of systemic juvenile idiopathic arthritis","volume":"26","author":"Jelusic","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2014.05.002_bib50","first-page":"823","article-title":"Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis","volume":"34","author":"Lotito","year":"2007","journal-title":"J\u00a0Rheumatol"},{"issue":"9","key":"10.1016\/j.berh.2014.05.002_bib51","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1002\/art.10389","article-title":"Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et\u00a0al","volume":"46","author":"Maeno","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.berh.2014.05.002_bib52","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/art.20268","article-title":"Increased interleukin-18 expression in bone marrow of a patient with systemic juvenile idiopathic arthritis and unrecognized macrophage-activation syndrome","volume":"50","author":"Maeno","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2014.05.002_bib53","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cyto.2012.11.025","article-title":"Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles","volume":"61","author":"Shimizu","year":"2013","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.berh.2014.05.002_bib54","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/art.38296","article-title":"Effectiveness of first line use of recombinant IL-1RA treatment in steroid naive systemic juvenile idiopathic arthritis: results of a prospective cohort study","volume":"66","author":"Vastert","year":"2014","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2014.05.002_bib55","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1189\/jlb.0602313","article-title":"Interleukin-18","volume":"73","author":"Gracie","year":"2003","journal-title":"J\u00a0Leukoc Biol"},{"issue":"7","key":"10.1016\/j.berh.2014.05.002_bib56","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0167-5699(00)01648-0","article-title":"Interleukin 18: a pleiotropic participant in chronic inflammation","volume":"21","author":"McInnes","year":"2000","journal-title":"Immunol Today"},{"issue":"3","key":"10.1016\/j.berh.2014.05.002_bib57","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1067\/mpd.2003.110","article-title":"Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome","volume":"142","author":"Grom","year":"2003","journal-title":"J\u00a0Pediatr"},{"issue":"9","key":"10.1016\/j.berh.2014.05.002_bib58","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/art.24750","article-title":"Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis","volume":"60","author":"de Jager","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.berh.2014.05.002_bib59","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0022-3476(96)70140-3","article-title":"Macrophage activation syndrome in systemic juvenile rheumatoid arthritis","volume":"129","author":"Grom","year":"1996","journal-title":"J\u00a0Pediatr"},{"issue":"5","key":"10.1016\/j.berh.2014.05.002_bib60","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/00002281-200209000-00012","article-title":"Macrophage activation syndrome","volume":"14","author":"Ravelli","year":"2002","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2014.05.002_bib61","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/gene.2012.3","article-title":"Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment","volume":"13","author":"Ravelli","year":"2012","journal-title":"Genes Immun"},{"key":"10.1016\/j.berh.2014.05.002_bib62","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev-med-041610-134208","article-title":"Familial and acquired hemophagocytic lymphohistiocytosis","volume":"63","author":"Janka","year":"2012","journal-title":"Annu Rev Med"},{"issue":"9783","key":"10.1016\/j.berh.2014.05.002_bib63","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","article-title":"Juvenile idiopathic arthritis","volume":"377","author":"Prakken","year":"2011","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.berh.2014.05.002_bib64","first-page":"1133","article-title":"Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis","volume":"34","author":"Behrens","year":"2007","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2014.05.002_bib65","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/art.22409","article-title":"First report of macrophage activation syndrome in hyperimmunoglobulinemia D with periodic fever syndrome","volume":"56","author":"Rigante","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.berh.2014.05.002_bib66","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/art.23734","article-title":"Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms","volume":"58","author":"Zhang","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2014.05.002_bib67","doi-asserted-by":"crossref","first-page":"e8663","DOI":"10.1371\/journal.pone.0008663","article-title":"Failure of interferon gamma to induce the anti-inflammatory interleukin 18 binding protein in familial hemophagocytosis","volume":"5","author":"Nold-Petry","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.berh.2014.05.002_bib68","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1365-2141.1999.01504.x","article-title":"Oversecretion of IL-18 in haemophagocytic lymphohistiocytosis: a novel marker of disease activity","volume":"106","author":"Takada","year":"1999","journal-title":"Br J Haematol"},{"issue":"1\u20132","key":"10.1016\/j.berh.2014.05.002_bib69","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/10428190109097673","article-title":"Interleukin-18 in hemophagocytic lymphohistiocytosis","volume":"42","author":"Takada","year":"2001","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.berh.2014.05.002_bib70","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.2010.134254","article-title":"A\u00a0multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)","volume":"70","author":"Quartier","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2014.05.002_bib71","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/art.30128","article-title":"Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series","volume":"63","author":"Nigrovic","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2014.05.002_bib72","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.2007.076034","article-title":"Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset still disease: preliminary experience in France","volume":"67","author":"Lequerre","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"32","key":"10.1016\/j.berh.2014.05.002_bib73","doi-asserted-by":"crossref","first-page":"13463","DOI":"10.1073\/pnas.0906988106","article-title":"IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells","volume":"106","author":"Guo","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.berh.2014.05.002_bib74","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1172\/JCI7317","article-title":"A\u00a0proinflammatory role for IL-18 in rheumatoid arthritis","volume":"104","author":"Gracie","year":"1999","journal-title":"J\u00a0Clin Invest"},{"issue":"12","key":"10.1016\/j.berh.2014.05.002_bib75","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.4049\/jimmunol.164.12.6495","article-title":"Combined effects of IL-12 and IL-18 on the induction of collagen-induced arthritis","volume":"164","author":"Leung","year":"2000","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.berh.2014.05.002_bib76","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4049\/jimmunol.166.1.517","article-title":"Reduced incidence and severity of collagen-induced arthritis in mice lacking IL-18","volume":"166","author":"Wei","year":"2001","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.berh.2014.05.002_bib77","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/art.23291","article-title":"Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers","volume":"58","author":"Nistala","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.berh.2014.05.002_bib78","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/rheumatology\/kep028","article-title":"Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis","volume":"48","author":"Nistala","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.berh.2014.05.002_bib79","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","article-title":"Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells","volume":"112","author":"Koenen","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.berh.2014.05.002_bib80","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/annrheumdis-2011-200598","article-title":"The toll-like receptor 4 agonist MRP8\/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis","volume":"71","author":"Holzinger","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.berh.2014.05.002_bib81","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0049-0172(78)90027-6","article-title":"Light- and electron-microscopic findings of juvenile rheumatoid arthritis synovium: comparison with normal juvenile synovium","volume":"7","author":"Wynne-Roberts","year":"1978","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.berh.2014.05.002_bib82","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/intimm\/11.4.535","article-title":"Molecular fingerprinting reveals non-overlapping T cell oligoclonality between an inflamed site and peripheral blood","volume":"11","author":"Wedderburn","year":"1999","journal-title":"Int Immunol"},{"issue":"1","key":"10.1016\/j.berh.2014.05.002_bib83","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2249.1993.tb03360.x","article-title":"Synovial fluid cells in juvenile arthritis: evidence of selective T cell migration to inflamed tissue","volume":"91","author":"Silverman","year":"1993","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"10.1016\/j.berh.2014.05.002_bib84","first-page":"2116","article-title":"Immunohistological characteristics of T cell infiltrates in different forms of childhood onset chronic arthritis","volume":"23","author":"Murray","year":"1996","journal-title":"J\u00a0Rheumatol"},{"issue":"2 Suppl.","key":"10.1016\/j.berh.2014.05.002_bib85","first-page":"271","article-title":"Pathologic aspects of juvenile chronic polyarthritis","volume":"20","author":"Bywaters","year":"1977","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2014.05.002_bib86","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrrheum.2012.149","article-title":"T\u00a0cells out of control-impaired immune regulation in the inflamed joint","volume":"9","author":"Wehrens","year":"2012","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"10.1016\/j.berh.2014.05.002_bib87","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.3899\/jrheum.090066","article-title":"Th17 transcription factor RORC2 is inversely correlated with FOXP3 expression in the joints of children with juvenile idiopathic arthritis","volume":"36","author":"Olivito","year":"2009","journal-title":"J\u00a0Rheumatol"},{"issue":"8","key":"10.1016\/j.berh.2014.05.002_bib88","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/art.30332","article-title":"Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis","volume":"63","author":"Cosmi","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2014.05.002_bib89","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.berh.2014.05.002_bib90","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol Rev"},{"issue":"10","key":"10.1016\/j.berh.2014.05.002_bib91","doi-asserted-by":"crossref","first-page":"6435","DOI":"10.4049\/jimmunol.172.10.6435","article-title":"CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis","volume":"172","author":"de Kleer","year":"2004","journal-title":"J\u00a0Immunol"},{"issue":"7","key":"10.1016\/j.berh.2014.05.002_bib92","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/art.11174","article-title":"The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10","volume":"48","author":"de Kleer","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.berh.2014.05.002_bib93","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2009-02-207118","article-title":"Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization","volume":"115","author":"van Loosdregt","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.berh.2014.05.002_bib94","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.immuni.2013.07.019","article-title":"Canonical Wnt signaling negatively modulates regulatory T cell function","volume":"39","author":"van Loosdregt","year":"2013","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.berh.2014.05.002_bib95","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.immuni.2013.05.018","article-title":"Stabilization of the transcription factor Foxp3 by the deubiquitinase USP7 increases Treg-cell-suppressive capacity","volume":"39","author":"van Loosdregt","year":"2013","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.berh.2014.05.002_bib96","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20460","article-title":"2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features","volume":"63","author":"Beukelman","year":"2011","journal-title":"Arthritis Care Res (Hoboken )"},{"issue":"2","key":"10.1016\/j.berh.2014.05.002_bib97","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.clim.2011.10.003","article-title":"Evidence and consensus based GKJR guidelines for the treatment of juvenile idiopathic arthritis","volume":"142","author":"Dueckers","year":"2012","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.berh.2014.05.002_bib98","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1172\/JCI2676","article-title":"Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells","volume":"102","author":"Genestier","year":"1998","journal-title":"J\u00a0Clin Invest"},{"issue":"5 Suppl. 61","key":"10.1016\/j.berh.2014.05.002_bib99","first-page":"S21","article-title":"How does methotrexate suppress inflammation?","volume":"28","author":"Cronstein","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2014.05.002_bib100","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1172\/JCI116884","article-title":"The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in\u00a0vivo model of inflammation","volume":"92","author":"Cronstein","year":"1993","journal-title":"J\u00a0Clin Invest"},{"issue":"Suppl. 2","key":"10.1016\/j.berh.2014.05.002_bib101","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/rheumatology\/XXXIV.suppl_4.30","article-title":"The antirheumatic agents sulphasalazine and methotrexate share an anti-inflammatory mechanism","volume":"34","author":"Cronstein","year":"1995","journal-title":"Br J Rheumatol"},{"issue":"8","key":"10.1016\/j.berh.2014.05.002_bib102","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/ard.60.8.729","article-title":"Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis","volume":"60","author":"Cutolo","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2014.05.002_bib103","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/art.10712","article-title":"Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68","volume":"48","author":"Montesinos","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.berh.2014.05.002_bib104","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/art.22643","article-title":"The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5'-nucleotidase: findings in a study of ecto-5'-nucleotidase gene-deficient mice","volume":"56","author":"Montesinos","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.berh.2014.05.002_bib105","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","article-title":"Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression","volume":"110","author":"Borsellino","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.berh.2014.05.002_bib106","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J\u00a0Exp Med"},{"issue":"1\u20132","key":"10.1016\/j.berh.2014.05.002_bib107","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11302-006-9050-y","article-title":"CD39 and control of cellular immune responses","volume":"3","author":"Dwyer","year":"2007","journal-title":"Purinergic Signal"},{"issue":"11","key":"10.1016\/j.berh.2014.05.002_bib108","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.4049\/jimmunol.0901881","article-title":"CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis","volume":"183","author":"Fletcher","year":"2009","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.berh.2014.05.002_bib109","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4049\/jimmunol.0803474","article-title":"High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population","volume":"185","author":"Moncrieffe","year":"2010","journal-title":"J\u00a0Immunol"},{"issue":"21","key":"10.1016\/j.berh.2014.05.002_bib110","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.2011.1671","article-title":"Factors associated with treatment response to etanercept in juvenile idiopathic arthritis","volume":"306","author":"Otten","year":"2011","journal-title":"J\u00a0Am Med Assoc"},{"issue":"8657","key":"10.1016\/j.berh.2014.05.002_bib111","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(89)90430-3","article-title":"Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis","volume":"2","author":"Brennan","year":"1989","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.berh.2014.05.002_bib112","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.berh.2003.09.010","article-title":"The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis","volume":"18","author":"Feldmann","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.berh.2014.05.002_bib113","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM200003163421103","article-title":"Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group","volume":"342","author":"Lovell","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.berh.2014.05.002_bib114","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa0706290","article-title":"Adalimumab with or without methotrexate in juvenile rheumatoid arthritis","volume":"359","author":"Lovell","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.berh.2014.05.002_bib115","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1002\/art.22838","article-title":"A\u00a0randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis","volume":"56","author":"Ruperto","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2014.05.002_bib116","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1084\/jem.20061531","article-title":"Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta","volume":"204","author":"Nadkarni","year":"2007","journal-title":"J\u00a0Exp Med"},{"issue":"3","key":"10.1016\/j.berh.2014.05.002_bib117","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.20040165","article-title":"Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy","volume":"200","author":"Ehrenstein","year":"2004","journal-title":"J\u00a0Exp Med"},{"issue":"1","key":"10.1016\/j.berh.2014.05.002_bib118","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1182\/blood-2005-11-4567","article-title":"TNF downmodulates the function of human CD4+CD25hi T-regulatory cells","volume":"108","author":"Valencia","year":"2006","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/j.berh.2014.05.002_bib119","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1478-6354-13-S1-S5","article-title":"Advances in rheumatology: new targeted therapeutics","volume":"13","author":"Tak","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10.1016\/j.berh.2014.05.002_bib120","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1002\/art.38132","article-title":"Anti-tumor necrosis factor alpha targets protein kinase B\/c-Akt-induced resistance of effector cells to suppression in juvenile idiopathic arthritis","volume":"65","author":"Wehrens","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.berh.2014.05.002_bib121","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/ard.2003.017798","article-title":"Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity","volume":"63","author":"de Kleer","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"9152","key":"10.1016\/j.berh.2014.05.002_bib122","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(98)05399-9","article-title":"Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis","volume":"353","author":"Wulffraat","year":"1999","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.berh.2014.05.002_bib123","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/art.22656","article-title":"Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial","volume":"56","author":"Brinkman","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2014.05.002_bib124","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/157488811794480726","article-title":"Restoration of the immune balance by autologous bone marrow transplantation in juvenile idiopathic arthritis","volume":"6","author":"Delemarre","year":"2011","journal-title":"Curr Stem Cell Res Ther"},{"issue":"2","key":"10.1016\/j.berh.2014.05.002_bib125","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/art.38261","article-title":"Brief report: autologous stem cell transplantation restores immune tolerance in experimental arthritis by renewal and modulation of the teff cell compartment","volume":"66","author":"Delemarre","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"15","key":"10.1016\/j.berh.2014.05.002_bib126","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1073\/pnas.0808144106","article-title":"In\u00a0vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses","volume":"106","author":"Evans","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.berh.2014.05.002_bib127","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/rheumatology\/kel346","article-title":"Distinct expression pattern of IFN-alpha and TNF-alpha in juvenile idiopathic arthritis synovial tissue","volume":"46","author":"Gattorno","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.berh.2014.05.002_bib128","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/art.22414","article-title":"Proinflammatory mediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis","volume":"56","author":"van Amelsfort","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"33","key":"10.1016\/j.berh.2014.05.002_bib129","doi-asserted-by":"crossref","first-page":"14751","DOI":"10.1073\/pnas.1003852107","article-title":"Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment","volume":"107","author":"Nistala","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.berh.2014.05.002_bib130","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1136\/annrheumdis-2011-201131","article-title":"TLR9 agonist CpG enhances protective nasal HSP60 peptide vaccine efficacy in experimental autoimmune arthritis","volume":"71","author":"Zonneveld-Huijssoon","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.berh.2014.05.002_bib131","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1136\/ard.2010.136994","article-title":"Bystander suppression of experimental arthritis by nasal administration of a heat shock protein peptide","volume":"70","author":"Zonneveld-Huijssoon","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.berh.2014.05.002_bib132","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1136\/annrheumdis-2012-201937","article-title":"Therapeutic approaches for the treatment of renal disease in juvenile systemic lupus erythematosus: an international multicentre PRINTO study","volume":"72","author":"Miettunen","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.berh.2014.05.002_bib133","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-156-5-201203060-00004","article-title":"Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial","volume":"156","author":"Bakker","year":"2012","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.berh.2014.05.002_bib134","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/art.10135","article-title":"Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis","volume":"46","author":"Mottonen","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"4 Suppl. 73","key":"10.1016\/j.berh.2014.05.002_bib135","first-page":"S27","article-title":"Long-term results of the FIN-RACo trial; treatment with a combination of traditional disease-modifying anti-rheumatic drugs is an excellent option in early rheumatoid arthritis","volume":"30","author":"Rantalaiho","year":"2012","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2014.05.002_bib136","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/art.34343","article-title":"Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis","volume":"64","author":"Wallace","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.berh.2014.05.002_bib137","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1136\/ard.2010.143347","article-title":"Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial","volume":"70","author":"Tynjala","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"13","key":"10.1016\/j.berh.2014.05.002_bib138","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2010.375","article-title":"Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial","volume":"303","author":"Foell","year":"2010","journal-title":"J\u00a0Am Med Assoc"},{"issue":"3","key":"10.1016\/j.berh.2014.05.002_bib139","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/ar4213","article-title":"What are the immunological consequences of long-term use of biological therapies for juvenile idiopathic arthritis?","volume":"15","author":"Swart","year":"2013","journal-title":"Arthritis Res Ther"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694214000515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694214000515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T11:58:59Z","timestamp":1689335939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694214000515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":139,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1521694214000515"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2014.05.002","relation":{},"ISSN":["1521-6942"],"issn-type":[{"type":"print","value":"1521-6942"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on research and clinical translation on specific clinical areas: From bench to bedside: How insight in immune pathogenesis can lead to precision medicine of severe juvenile idiopathic arthritis","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2014.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}